Aurinia Pharmaceuticals (AUPH) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts AUPH Hot Sheet
Join SI Premium – FREE
Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q2 EPS of $0.28, $0.05 better than the analyst estimate of $0.23. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $80.56 million.
For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Legacy Gold names interim CFO after Andrew Dunlop resigns
- Goldgroup Mining launches $75M private placement with $60M committed
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
